Evolution

BDR Pharmaceutical's Growth Over The Years

BDR has evolved to become a leading complex generics player

2002-2014 Initial Phase
  • 2003: BDR Pharma was started by Mr. Dharmesh Shah as merchant export business
  • 2010: Started API manufacturing business through acquisition of an entity in Vadodara
  • 2010-2014: Started Domestic CDMO business. Developed and launched 40+ drugs, marketed by leading generic players in India
2015-2021 Foundation Phase
  • 2015-17: Established OSD facility in Padra and expanded the Vadodara API facility
  • 2019: Established a new and a large R&D centre in Halol, serves as an intellectual hub for BDR
  • FY21: Forayed into Europe (reg. markets) and expanded its domestic formulations business

    One of the earliest players to identify and develop Covid drugs by leveraging its R&D skills

  • FY22: Setup up a new general OSD and injectables facility in Halol
2022-2026 Growth Phase
  • FY22-FY26: Commissioning of Onco injectables facility in Halol

    Setting up of a new Biosimilars block

    International expansion through manufacturing setup in Algeria and Russia

    Expansion of existing manufacturing (API and Oral OSD) and R&D centre

    Launch of 40+ new complex molecules going off-patent

  • This will enable BDR to shift its manufacturing in-house (leading to significant margin expansion) and foray into regulated markets
Milestones

Our Achievements

BDR Pharma is a leading pharmaceutical company that has achieved remarkable success in the industry. The company has been at the forefront of innovation and development, with several groundbreaking products and services. We have consistently pushed the boundaries of what is possible in the industry and have become a leader in the pharmaceutical domain.